Medtronic's Inceptiv™ Closed-Loop Spinal Cord Stimulator Receives FDA Approval for Chronic Pain Treatment

Medtronic, a leader in healthcare technology, has announced the FDA approval of the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for treating chronic pain. Inceptiv is the first Medtronic SCS device to feature closed-loop technology, which senses biological signals along the spinal cord and automatically adjusts stimulation in real time to align with daily movements. This advancement represents a significant leap forward in chronic pain treatment, providing personalized therapy tailored to each patient's needs.

Previous
Previous

Member of Congress ‘flies out’ to Nanoscope Therapeutics

Next
Next

McKesson Chosen as Specialty Pharmacy for OJEMDATM for Pediatric Low-Grade Glioma Treatment